Latest Breaking News On - Non alcoholic fatty liver disease - Page 24 : comparemela.com

ENDRA Life Sciences Expands Intellectual Property with Issuance of U S and European Patents

ENDRA Life Sciences Expands Intellectual Property with Issuance of U S and European Patents
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lyvonne briggsIrina pestrikovaFrancois michelonSecurities exchangeCompany contactLife sciences incLife sciencesSciences incThermo acoustic enhanced ultrasoundFrequency applicatorThermoacoustic imaging systemMonitoring tissue temperatureDetermining fractional fat contentChief executive officer francoisNon alcoholic fatty liver diseaseNon alcoholic steatohepatitis

Siddhalepa Liv-Pro: The Proven Natural Remedy for Fatty Liver Disease

Prior to the coronavirus pandemic, Siddhalepa took a breakthrough decision to bring to light their ayurvedic capsule that best treat those with the fatty liver disease. Made from Heen Bovitiya and Aloe Vera, clinical trials at Siddhalepa Ayurveda Hospital in Mount Lavinia which started early 2017, h

Sri lankaUnited kingdomSouthern provinceMount laviniaSiddhalepa livAloe veraLankani hettigodaDepartment of ayurvedaNational health serviceHettigoda industries pvt ltdHeen bovitiyaSiddhalepa ayurveda hospitalSiddhalepa liv proNon alcoholic fatty liver diseaseAlcoholic fatty liver diseaseDirector research

Anti-diabetic Drug Semaglutide for Patients With Fatty Liver Disease

The potential effectiveness of semaglutide, an anti-diabetic and anti-obesity medication, in managing fibrosis caused by NAFLD has been studied.

United statesDrug administrationNational institutes of healthNational institutesNon alcoholic fatty liver diseaseLiver disease treatment

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Kellyo wilsonKelly wilsonBiostax corpDrug administrationTherapeutics incExchange commissionTaiwanj pharmaceuticalsAimmune therapeuticsInvestigational new drug applicationsNonalcoholic liver diseaseAutoimmune hepatitisOrphan designationNon alcoholic fatty liver diseaseNon alcoholic steatohepatitis

ENDRA Life Sciences (NDRA) Submits De Novo Request for TAEUS

ENDRA Life Sciences (NDRA) Submits De Novo Request for TAEUS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Francois michelonLyvonne briggsIrina pestrikovaSecurities exchangeLife sciencesDrug administrationEndra life sciences incLife sciences incExchange commissionSciences incThermo acoustic enhanced ultrasoundNon alcoholic fatty liver diseaseChief executive officer francoisSecurities actSecurities exchange actRisk factors